K

Kyverna Therapeutics

60 employees

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
autoimmune
cell therapy
Therapeutics
lupus
Life Science

Date founded

2018

Funding rounds raised

Total raised

$85M

from 10 investors over 10 rounds

K

Kyverna Therapeutics raised $85M on January 26, 2022

Investors: LYFE Capital, Hudson Bay Capital Management LP, Westlake Village BioPartners®, Intellia Therapeutics, Inc., Insight Partners, Vida Ventures, LLC, RTW Investments, LP and Northpond Ventures

K

Kyverna Therapeutics raised $25M on January 13, 2020

Investors: Vida Ventures, LLC and Westlake Village BioPartners®

FAQ